Virus-positive Mucocutaneous Ulcer Research Articles

Age-related Epstein-Barr virus-positive cutaneous ulcer arising after a self-limited subcutaneous abscess: a case report.

IntroductionEpstein-Barr virus-positive mucocutaneous ulcer is a newly recognized clinicopathologic entity in the spectrum of Epstein-Barr virus-positive lymphoproliferative disorders. This entity is characterized by a self-limited, indolent course.Case presentationWe report the case of a 74-year-old, type 2 diabetic man who presented with an ulceroinfiltrative skin lesion on the left side of his neck. Histological examination showed that the lesion consisted of large atypical cells, some with Hodgkin-Reed-Sternberg-like morphology, in the midst of reactive lymphocytes, plasma cells, eosinophils and histiocytes. The atypical cells were partially positive for CD45, CD20, CD79a, CD30, B-cell lymphoma 2 and latent membrane protein 1 (CS.1-4), and negative for CD15, B-cell lymphoma 6 and CD10. In situ hybridization for Epstein-Barr virus-encoded ribonucleic acid was positive. Two years before, the patient had been diagnosed with a self-limited subcutaneous abscess in the same anatomic area that healed after antibiotic therapy.ConclusionOlder patients with positive Epstein-Barr virus serology may develop B-cell lymphoproliferations due to age-related immune suppression. Epstein-Barr virus-encoded ribonucleic acid testing and clonality analysis, eventually complemented with close clinical follow-up, should be performed for suspicious inflammatory lesions in older patients.

Epstein-Barr virus–positive mucocutaneous ulcer of the oral cavity: the importance of having a detailed clinical history to reach a correct diagnosis

Epstein-Barr virus-positive mucocutaneous ulcer (EBVMCU) is a recently recognized clinicopathological entity. It presents as an ulcerative lesion with lymphoma-like histologic features and is clinically associated with various types of immunosuppression. EBVMCU lesions respond well to conservative measures aimed at correcting the underlying immunosuppression. The case described clearly demonstrates the importance of appropriately completing biopsy submission forms with a detailed clinical history, thus aiding the histopathologist in reaching the correct diagnosis, particularly in pathologic conditions that have similar or overlapping histopathological features. Failure to do so may lead to incorrect diagnosis and management.

Cytomorphological Features of Epstein Barr Virus-Related Lymphoproliferative Disorder Associated With Epstein Barr Virus-Positive Mucocutaneous Ulcer

Cytomorphological Features of Epstein Barr Virus-Related Lymphoproliferative Disorder Associated With Epstein Barr Virus-Positive Mucocutaneous Ulcer

High frequency of Epstein-Barr virus–infected lymphocytes in pilonidal cysts

Circulating memory B cells are considered as the main reservoir for Epstein-Barr virus. Several studies identified the presence of Epstein-Barr virus-infected B cells in the lesions of Crohn disease and ulcerative colitis suggesting that colon mucosa with chronic inflammation could be a potential site of Epstein-Barr virus replication. However, whether skin could be also an Epstein-Barr virus reservoir has not yet been investigated. We used pilonidal cysts as a model of skin chronic inflammation, and we found in 20 (55.6%) of 36 cases variable amounts of Epstein-Barr virus-infected cells as assessed by in situ hybridization using Epstein-Barr virus-encoded RNA probe and immunostainings. Most (95%) of the Epstein-Barr virus-positive cells were of B-cell phenotype, whereas scattered cells were double stained with Epstein-Barr virus-encoded RNA probes and T-cell markers. Epstein-Barr virus-encoded RNA+ cell density correlated with the intensity of inflammation. This density was similar to that observed in chronic diverticulitis but higher when compared with appendicitis, suggesting that chronic rather than acute inflammation facilitates the recruitment of Epstein-Barr virus-infected cells in diseased tissues. Altogether, these data suggest that, in immunocompetent patients, skin inflammatory lesions contain Epstein-Barr virus-infected cells exhibiting latency type I. Moreover, skin-like gastrointestinal mucosa is a potential site of Epstein-Barr virus replication and spreading. Our results may explain the pathogenesis of the Epstein-Barr virus-positive mucocutaneous ulcer.